LifeSciences Consultants (LSC)
LifeSciences Consultants (LSC) is a global healthcare strategy consultancy with over 20 years of experience supporting biopharma, MedTech, Diagnostics, and healthcare organizations worldwide. They focus on helping clients introduce therapies to market, redefine care pathways, create innovative funding schemes, and foster collaborations within healthcare ecosystems. Their expertise spans multiple therapeutic areas including rare diseases, cell & gene therapy, neurology, cardiology, oncology, and more. LSC offers tailored commercial insights, proprietary methodologies, and strategic support across the healthcare value chain to drive successful business outcomes and improve patient care.
Industries
Nr. of Employees
small (1-50)
LifeSciences Consultants (LSC)
Products
Pre-commercialization and Launch Strategy
Consulting and strategy services focused on life sciences pre-commercialization, launch excellence, and market access planning.
Inline Brand Optimization
Consulting capability focused on optimizing inline pharmaceutical and medical brand strategies, pricing models, market access, and commercial harmonization.
Product development and commercialization support for an imaging biomarker in Alzheimer’s
Consulting and support services for product development, market analysis, clinical validation, and commercialization of an optical coherence tomography (OCT) and OCT-angiography imaging biomarker for Alzheimer's disease.
Payers & Insurances
Consulting and strategy services focusing on major reimbursement, pricing challenges, therapy pricing, and market access for life sciences products with a wide-spread network of global payers.
Life Sciences Due Diligence Consulting
Strategic commercial due diligence services empowering clients to make informed investment decisions in the broad Healthcare Industry, supporting PE/VC and corporates across all stages of the investment life cycle.
Companion diagnostic strategy for launch of novel biomarker-driven oncology drug
Pre-commercialization and launch strategy consulting case in the biopharma oncology sector.
Pre-commercialization and Launch Strategy
Consulting and strategy services focused on life sciences pre-commercialization, launch excellence, and market access planning.
Inline Brand Optimization
Consulting capability focused on optimizing inline pharmaceutical and medical brand strategies, pricing models, market access, and commercial harmonization.
Product development and commercialization support for an imaging biomarker in Alzheimer’s
Consulting and support services for product development, market analysis, clinical validation, and commercialization of an optical coherence tomography (OCT) and OCT-angiography imaging biomarker for Alzheimer's disease.
Payers & Insurances
Consulting and strategy services focusing on major reimbursement, pricing challenges, therapy pricing, and market access for life sciences products with a wide-spread network of global payers.
Life Sciences Due Diligence Consulting
Strategic commercial due diligence services empowering clients to make informed investment decisions in the broad Healthcare Industry, supporting PE/VC and corporates across all stages of the investment life cycle.
Companion diagnostic strategy for launch of novel biomarker-driven oncology drug
Pre-commercialization and launch strategy consulting case in the biopharma oncology sector.
Services
Development of brand, portfolio and go-to-market strategies including launch sequencing, positioning and lifecycle management.
Design of reimbursement strategies, pricing models and payer engagement plans to support market access.
Clinical and commercial case development, evidence-generation planning, and go-to-market roadmaps for digital therapeutics, connected platforms and SaMD.
Optimization of clinical development plans, trial feasibility assessment and prioritized evidence generation to support regulatory and commercial objectives.
Market entry planning, regulatory and payer landscape assessment and adaptation of commercial approaches for new geographies including emerging markets.
Pre-deal commercial/vendor due diligence, gap analysis of hardware/software offerings and post-acquisition planning to support investment decisions and exits.
Development of brand, portfolio and go-to-market strategies including launch sequencing, positioning and lifecycle management.
Design of reimbursement strategies, pricing models and payer engagement plans to support market access.
Clinical and commercial case development, evidence-generation planning, and go-to-market roadmaps for digital therapeutics, connected platforms and SaMD.
Optimization of clinical development plans, trial feasibility assessment and prioritized evidence generation to support regulatory and commercial objectives.
Market entry planning, regulatory and payer landscape assessment and adaptation of commercial approaches for new geographies including emerging markets.
Pre-deal commercial/vendor due diligence, gap analysis of hardware/software offerings and post-acquisition planning to support investment decisions and exits.
Expertise Areas
- Commercial strategy and launch planning
- Market access and reimbursement strategy
- Digital health and SaMD commercialization
- MedTech and diagnostics commercialization
Key Technologies
- Connected devices and remote patient monitoring
- Digital therapeutics
- Software-as-a-medical-device (SaMD)
- AI-enabled imaging and diagnostic algorithms
News & Updates
This initiative aims to revolutionize diabetes care by improving health outcomes for people living with diabetes (PwD) while reducing healthcare costs through a value-based care model. The project incorporates a digital therapy platform, sustainable procurement, and adoption strategies. LSC contributes its expertise in Health Economics to support the development of a robust value-based care framework.
This initiative aims to revolutionize diabetes care by improving health outcomes for people living with diabetes (PwD) while reducing healthcare costs through a value-based care model. The project incorporates a digital therapy platform, sustainable procurement, and adoption strategies. LSC contributes its expertise in Health Economics to support the development of a robust value-based care framework.